Maven Securities LTD Kodiak Sciences Inc. Transaction History
Maven Securities LTD
- $1.61 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding KOD
# of Institutions
111Shares Held
43MCall Options Held
87.8KPut Options Held
7.3K-
Baker Bros. Advisors LP New York, NY17.3MShares$51.2 Million1.15% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$11.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.72MShares$5.1 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$4.9 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.61MShares$4.78 Million0.24% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $154M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...